Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy: Case report

By sjmartinez • July 22, 2024

Cheng JJ, Shen J, Suresh Y, Akopyan NA, Kapoor NS. Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy: Case report. Int J Surg Case Rep. 2024 Jul 18;122:110050. doi: 10.1016/j.ijscr.2024.110050. Epub ahead of print. PMID: 39033702.

Tags: Case report, Hematology/Oncology, Male breast cancer, prostate cancer, Publications, Testosterone replacement

Related Posts

Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket Trial

Goldman JW, Bueno AM, Dooms C, Jhaveri K, de Miguel M, Piha-Paul SA, Unni N, Zick A, Mahipal A, Suga JM, Naltet C, Antoñanzas M,[...]

Results from a phase 1b study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small cell lung cancer (NSCLC) after progression on prior osimertinib

Horinouchi H, Cho BC, Camidge DR, Goto K, Tomasini P, Li Y, Vasilopoulos A, Brunsdon P, Hoffman D, Shi W, Bolotin E, Blot V, Goldman[...]

ZNFX1 functions as a master regulator of epigenetically induced pathogen mimicry and inflammasome signaling in cancer

Stojanovic L, Abbotts R, Tripathi K, Coon CM, Rajendran S, Abbasi Farid E, Hostetter G, Guarnieri JW, Wallace DC, Liu S, Wan J, Calendo G,[...]